ATE110745T1 - Wachstumshormonkristalle und verfahren zu deren herstellung. - Google Patents

Wachstumshormonkristalle und verfahren zu deren herstellung.

Info

Publication number
ATE110745T1
ATE110745T1 AT91913240T AT91913240T ATE110745T1 AT E110745 T1 ATE110745 T1 AT E110745T1 AT 91913240 T AT91913240 T AT 91913240T AT 91913240 T AT91913240 T AT 91913240T AT E110745 T1 ATE110745 T1 AT E110745T1
Authority
AT
Austria
Prior art keywords
production
growth hormone
crystals
hgh
divalent cation
Prior art date
Application number
AT91913240T
Other languages
English (en)
Inventor
Flemming Junker
Claus Friis Theisen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE110745T1 publication Critical patent/ATE110745T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT91913240T 1990-07-13 1991-07-12 Wachstumshormonkristalle und verfahren zu deren herstellung. ATE110745T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK168790A DK168790D0 (de) 1990-07-13 1990-07-13

Publications (1)

Publication Number Publication Date
ATE110745T1 true ATE110745T1 (de) 1994-09-15

Family

ID=8107212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913240T ATE110745T1 (de) 1990-07-13 1991-07-12 Wachstumshormonkristalle und verfahren zu deren herstellung.

Country Status (17)

Country Link
US (1) US6117984A (de)
EP (1) EP0540582B1 (de)
JP (1) JP2524446B2 (de)
AT (1) ATE110745T1 (de)
AU (1) AU666465B2 (de)
BG (1) BG61267B1 (de)
CA (1) CA2086087C (de)
DE (1) DE69103755T2 (de)
DK (2) DK168790D0 (de)
ES (1) ES2060399T3 (de)
HU (2) HU210323B (de)
IE (1) IE67054B1 (de)
NZ (1) NZ238904A (de)
PT (1) PT98297B (de)
RU (1) RU2108341C1 (de)
WO (1) WO1992000998A1 (de)
ZA (1) ZA915446B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894023B1 (en) * 1990-07-13 2005-05-17 Novo Nordisk A/S Growth hormone crystals and a process for production of these GH-crystals
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
ES2185625T3 (es) * 1991-12-20 2003-05-01 Novo Nordisk As Formulacion farmaceutica estabilizada que incluye hormona de crecimiento e histidina.
SE9302278D0 (sv) * 1992-10-28 1993-07-02 Kabi Pharmacia Ab Growth hormone
DK0946169T3 (da) * 1996-12-20 2003-04-22 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af et præparat med vedvarende frigivelse
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6451347B1 (en) 1999-03-01 2002-09-17 Alkermes Controlled Therapeutics, Inc. Method for purifying human growth hormone
DE60000622T2 (de) * 1999-06-10 2003-02-27 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Einkapselung von kristallen mit mehrschichtigem überzug
US6566329B1 (en) 1999-06-28 2003-05-20 Novo Nordisk A/S Freeze-dried preparation of human growth hormone
MXPA03001092A (es) 2000-08-07 2003-09-25 Nektar Therapeutics Al Corp Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada.
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
AU2001294459A1 (en) 2000-10-06 2002-04-15 Jagotec Ag A controlled-release, parenterally administrable microparticle preparation
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
US7105181B2 (en) 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
SE0201599D0 (sv) 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
ZA200505305B (en) * 2002-12-31 2007-07-25 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
EP2460530A3 (de) 2002-12-31 2012-08-29 Althea Technologies, Inc. Kristalle des menschlichen Wachstumshormons und Verfahren zu ihrer Herstellung
ZA200505306B (en) * 2002-12-31 2006-09-27 Altus Pharmaceuticals Inc Complexes of protein crystals and ionic polymers
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
EP1976551A4 (de) * 2005-12-23 2009-12-30 Altus Pharmaceuticals Inc Zusammensetzungen mit polykation-komplex-proteinkristallen und behandlungsverfahren damit
AU2007333959A1 (en) * 2006-12-18 2008-06-26 Altus Pharmaceuticals Inc. Human growth hormone formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA653324A (en) * 1962-12-04 G. Brink Norman Growth hormone and methods of preparing the same
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2174862A (en) * 1938-12-30 1939-10-03 Frederick Stearns & Company Process of producing crystalline insulin
US2595278A (en) * 1950-04-28 1952-05-06 Armour & Co Preparation of insulin from pancreas glands
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US2897117A (en) * 1955-02-10 1959-07-28 Univ Alberta Insulin process
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
ATE62598T1 (de) * 1984-10-04 1991-05-15 Monsanto Co Verzoegerte freisetzung biologisch aktiver somatotropine.
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
IL85255A0 (en) * 1987-01-30 1988-07-31 Int Minerals & Chem Corp Recovery of somatotropin from dilute aqueous solutions
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
EP0355460B1 (de) * 1988-08-24 2000-12-27 American Cyanamid Company Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
US5109117A (en) * 1990-06-26 1992-04-28 Monsanto Company Method of somatotropin naturation using urea and a soluble organic alcohol
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
US5780599A (en) * 1990-07-13 1998-07-14 Novo Nordisk A/S Growth hormone crystals and a process for production of growth hormone crystals

Also Published As

Publication number Publication date
DK168790D0 (de) 1990-07-13
DE69103755D1 (de) 1994-10-06
DE69103755T2 (de) 1995-02-23
EP0540582B1 (de) 1994-08-31
AU666465B2 (en) 1996-02-15
NZ238904A (en) 1993-04-28
BG61267B1 (en) 1997-04-30
US6117984A (en) 2000-09-12
IE67054B1 (en) 1996-02-21
RU2108341C1 (ru) 1998-04-10
PT98297A (pt) 1992-05-29
BG97281A (bg) 1994-03-24
ES2060399T3 (es) 1994-11-16
CA2086087C (en) 1999-09-14
HU9300067D0 (en) 1993-04-28
AU8284691A (en) 1992-02-04
DK0540582T3 (da) 1995-01-30
JP2524446B2 (ja) 1996-08-14
WO1992000998A1 (en) 1992-01-23
JPH05507497A (ja) 1993-10-28
HU210323B (en) 1995-03-28
CA2086087A1 (en) 1992-01-14
IE912444A1 (en) 1992-01-15
PT98297B (pt) 1999-01-29
ZA915446B (en) 1992-03-25
EP0540582A1 (de) 1993-05-12
HUT64086A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
ATE110745T1 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
HUT44793A (en) Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
IT1179635B (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea
YU45724B (sh) Postupak za dobijanje kristalnog kalcijum pseudomonata ili njegovog hidrata
ZA885192B (en) Pharmaceutical preparations
HU893408D0 (en) Process for the production of glycosamino-glucane salts and medical preparations containing them
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
PT84064A (en) Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
HUT33996A (en) Composition for stimulating growth of plants containing amino-phenyl-ethyl-amine derivatives and process for producing the active agents
HUT45972A (en) Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
HUT47558A (en) Process for production of 12-halogene-forscoline derivatives and medical compositions containing them as active substance
HU912287D0 (en) Process for the production of sulphur-substituted mevin acid derivatives and medical preparations containing them
EP0257418A3 (en) Oxirane-pseudo-oligosaccharides, process for their synthesis, their use and pharmaceutical preparations
HUT47569A (en) Process for production of derivatives of perhydrotiazepin and perhydroazepin and medical compositions containing them as active substance
HU9201483D0 (en) Process for the production of 1h-rh-analogues'acid additive salts, and for the production of medical preparations containing them
HU9200116D0 (en) Process for the production of novel kinoline-8-carbonic acid derivatives and medical preparations containing them
HU904860D0 (en) Process for the production of medical preparations containing isoflavonic derivatives or salts thereof as active agents
ATE124945T1 (de) 2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee